Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center — Rochester, New York

Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center is a clinical research site located in Rochester, New York, United States 14621.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center has participated in 2 clinical trials.

Therapeutic areas: High Risk MDS, Multiple Myeloma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center?

Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center conducted?

Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center has 2 clinical trials on record. Their work covers High Risk MDS, Multiple Myeloma.

Is Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center accredited by Crixeo Health?

Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.